US SEC Trading Suspension Halt Orders — September 11, 2026

USA Trading Suspensions

By Gunpowder Editorial ·

3 high priority 3 total filings analysed

Executive Summary

All three filings concern Nasdaq minimum bid price compliance failures, signaling a cluster of micro-cap distress driven by sustained sub-$1.00 share prices. Fractyl Health (GUTS) faces imminent delisting after exhausting its 180-day grace period, but has proposed a reverse stock split (1-for-5 to 1-for-15) and will request a hearing to stay the delisting.

Greenland Technologies (GTEC) received a second 180-day extension until March 8, 2027, providing temporary relief but with continued delisting risk if compliance is not achieved. Glimpse Group (BTLN) received a Staff Determination to delist, with an appeal deadline of September 18, 2026, and plans to request a hearing. All three companies are considering or have proposed reverse stock splits as a remedy, a common but often ineffective strategy that can trigger further declines. The cluster suggests a broader trend of micro-cap liquidity and valuation pressures, with no positive period-over-period trends or insider buying to offset the negative outlook.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from September 10, 2026.

Investment Signals (8)

  • Fractyl Health (GUTS) (BEARISH)
    ▲

    Received delisting notice after failing to regain $1.00 bid price by September 9, 2026; proposed reverse stock split (1-for-5 to 1-for-15) and hearing request to stay delisting

  • Greenland Technologies (GTEC) (BEARISH)
    ▲

    Granted second 180-day compliance period until March 8, 2027; must maintain $1.00 bid for 10 consecutive days to regain compliance

  • Glimpse Group (BTLN) (BEARISH)
    ▲

    Received Staff Determination to delist; appeal deadline September 18, 2026; hearing request will stay suspension

  • Fractyl Health (GUTS) (BEARISH)
    ▲

    Reverse stock split proposal indicates management's attempt to regain compliance, but historical success rates are low

  • Greenland Technologies (GTEC) (BEARISH)
    ▲

    Extension provides temporary relief, but failure to comply by March 2027 could lead to delisting

  • Glimpse Group (BTLN) (BEARISH)
    ▲

    Appeal process may provide short-term stay, but delisting risk remains high

  • All Three Companies (BEARISH)
    ▲

    No insider buying or positive period-over-period trends reported; management conviction appears low

  • Sector-wide (BEARISH)
    ▲

    Cluster of bid price failures suggests broader micro-cap liquidity crisis, potentially signaling market-wide risk aversion

Risk Flags (6)

  • Fractyl Health (GUTS) [HIGH RISK]
    ▼

    Delisting imminent if hearing fails; reverse stock split may not stabilize price

  • Greenland Technologies (GTEC) [HIGH RISK]
    ▼

    Second extension is final; failure by March 8, 2027 leads to delisting

  • Glimpse Group (BTLN) [HIGH RISK]
    ▼

    Staff Determination issued; appeal must be filed by September 18, 2026 or delisting proceeds

  • All Three Companies [HIGH RISK]
    ▼

    Reverse stock splits often lead to further price declines post-implementation

  • All Three Companies [HIGH RISK]
    ▼

    No positive period-over-period trends or insider buying to offset negative sentiment

  • All Three Companies [HIGH RISK]
    ▼

    Regulatory halts and delisting processes can trigger forced selling and liquidity crunches

Opportunities (5)

  • Fractyl Health (GUTS) (OPPORTUNITY)
    ◆

    Hearing request may provide temporary stay; if reverse split approved and price stabilizes, could regain compliance

  • Greenland Technologies (GTEC) (OPPORTUNITY)
    ◆

    Extended deadline provides time to execute reverse split; if successful, could regain compliance by March 2027

  • Glimpse Group (BTLN) (OPPORTUNITY)
    ◆

    Appeal process may delay delisting; if successful, could provide time for strategic alternatives

  • All Three Companies (OPPORTUNITY)
    ◆

    Potential for short-term trading opportunities around hearing dates and reverse split announcements

  • All Three Companies (OPPORTUNITY)
    ◆

    If reverse splits succeed, stocks may see temporary price appreciation as compliance is regained

Sector Themes (4)

  • Micro-Cap Distress Cluster
    ◆

    Three companies in the same stream facing bid price compliance failures within 24 hours, indicating a broader trend of micro-cap liquidity and valuation pressures [IMPLICATION: Sector-wide risk aversion]

  • Reverse Split Reliance
    ◆

    All three companies are considering or have proposed reverse stock splits as a remedy, a common but often ineffective strategy [IMPLICATION: High failure rate]

  • Regulatory Deadline Pressure
    ◆

    All three companies face tight deadlines (September 9-18, 2026) for compliance or appeals, creating time-sensitive catalysts [IMPLICATION: Increased volatility]

  • No Positive Fundamentals
    ◆

    None of the filings report positive period-over-period trends or insider buying, suggesting fundamental deterioration [IMPLICATION: Negative outlook]

Watch List (5)

  • Fractyl Health (GUTS) (WATCH)
    👁

    Hearing request and reverse split vote; monitor for hearing date and stockholder approval

  • Greenland Technologies (GTEC) (WATCH)
    👁

    Monitor for reverse split announcement and compliance progress by March 8, 2027

  • Glimpse Group (BTLN) (WATCH)
    👁

    Appeal deadline September 18, 2026; monitor for hearing panel decision

  • All Three Companies (WATCH)
    👁

    Watch for insider trading activity following delisting notices

  • All Three Companies (WATCH)
    👁

    Monitor for additional regulatory filings or press releases regarding compliance efforts

Filing Analyses (3)
FRACTYL HEALTH, INC. 8-K negative materiality 9/10

11-09-2026

Fractyl Health, Inc. (GUTS) received a delisting notice from Nasdaq on September 10, 2026, because its common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days and did not regain compliance within the 180-day grace period ending September 9, 2026. The company intends to request a hearing to stay the delisting and has proposed a reverse stock split (1-for-5 to 1-for-15) to regain compliance. The stock's continued listing is uncertain pending the hearing process.

  • · The company filed a proxy statement on August 24, 2026, seeking stockholder approval for a reverse stock split to regain compliance.
  • · The hearing request will automatically stay any suspension or delisting pending the conclusion of the hearings process.
Greenland Technologies Holding Corp. 8-K negative materiality 9/10

11-09-2026

Greenland Technologies Holding Corp. (GTEC) received a Nasdaq letter on September 10, 2026, granting a second 180-day compliance period until March 8, 2027, to regain the minimum $1.00 bid price requirement. The company had previously failed to meet Nasdaq Listing Rule 5550(a)(2) and did not cure by the initial September 8, 2026 deadline. While the extension provides temporary relief, failure to comply by March 2027 could lead to delisting, and the company is considering a reverse stock split as a potential remedy.

  • · Initial compliance deadline was September 8, 2026; company failed to meet it.
  • · Company must maintain a closing bid price of at least $1.00 for 10 consecutive business days to regain compliance.
  • · Nasdaq may extend the required compliance period to up to 20 consecutive business days at its discretion.
  • · If compliance is not achieved by March 8, 2027, Nasdaq will issue a delisting notice; the company may appeal.
  • · Company is considering a reverse stock split as a potential cure.
Glimpse Group, Inc. 8-K negative materiality 9/10

11-09-2026

Brightline Interactive, Inc. (BTLN) received a Staff Determination from Nasdaq on September 11, 2026, to delist its common stock for failing to maintain a minimum bid price of $1.00 per share (Bid Price Requirement). The company had been given 180 days to regain compliance but failed to do so by the September 9, 2026 deadline. Brightline plans to appeal the determination by requesting a hearing before a Nasdaq Hearings Panel by September 18, 2026, which would temporarily stay the suspension and delisting process.

  • · The initial deficiency notice was received on March 13, 2026.
  • · The compliance deadline was September 9, 2026.
  • · The appeal deadline is September 18, 2026 at 4:00 p.m. Eastern Time.
  • · The company's common stock trades under the symbol BTLN on The Nasdaq Stock Market LLC.
  • · The company is an emerging growth company.

Get daily alerts with 8 investment signals, 6 risk alerts, 5 opportunities and full AI analysis of all 3 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US SEC Trading Suspension Halt Orders

🇺🇸 More from United States

View all →